Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 2(30), p. 143-152, 2020

Journal article published in 2020 by Mahmoud Mohammadi

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by